Quality of life and clusters of patient characteristics in individuals with statin intolerance

Back

ESC Professional Premium Access

Quality of life and clusters of patient characteristics in individuals with statin intolerance

Session: Lipid-lowering drugs: new insights

Topic: Lipids

Speaker: Doctor P. Stuerzebecher (Leipzig, DE)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Paulina Elena Stuerzebecher

University hospital Leipzig AoR, Leipzig (Germany)

0 follower

7 more presentations in this session

The cardiovascular polypill strategy (acetyl salicylic acid, atorvastatin, ramipril) as baseline treatment after a cardiovascular event supported by compelling evidence: a global expert consensus

Speaker: Doctor J. Gonzalez Juanatey (Santiago de Compostela, ES)

Combination of moderate-intensity statins and ezetimibe versus high-intensity statins alone for primary prevention of cardiovascular events

Speaker: Doctor L. Godoy (Toronto, CA)

Proprotein convertase subtilisin/kexin type 9 levels and the risk of cardiovascular events in statin-treated patients with cardiovascular disease

Speaker: Assistant Professor M. Gohbara (Yokohama, JP)

Safety and Efficacy of Moderate-intensity statin plus ezetimibe versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease: a meta-analysis

Speaker: Doctor F. Alves Kelly (Sao Paulo, BR)

Efficacy and severity of side-effects of rosuvastatin compared to other statins post-heart-transplantation

Speaker: Ms B. Van Dijk (Rotterdam, NL)

Access the full session

Lipid-lowering drugs: new insights

Speakers: Doctor P. Stuerzebecher, Doctor J. Gonzalez Juanatey, Doctor L. Godoy, Assistant Professor M. Gohbara, Doctor F. Alves Kelly...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources